Neutrophils Inhibit CD8 T Cells Immune Response by Arginase-1 Signaling in Patients with Sepsis
Overview
Affiliations
Background: Patients with sepsis often exhibit an acute inflammatory response, followed by an immunosuppressive phase with a poor immune response. However, the underlying mechanisms have not been fully elucidated.
Methods: We sought to comprehensively characterize the transcriptional changes in neutrophils of patients with sepsis by transcriptome sequencing. Additionally, we conducted a series of experiments, including real-time quantitative polymerase chain reaction (RT-qPCR) and flow cytometry to investigate the role of arginase-1 signaling in sepsis.
Results: Through the analysis of gene expression profiles, we identified that the negative regulation of T cell activation signaling was enriched, and the expression of arginase-1 was high in neutrophils from patients with sepsis. Furthermore, we conducted flow cytometry and found that the function of CD8 T cells in septic patients was impaired. Moreover, neutrophils from septic patients inhibited the percentage of polyfunctional effector CD8 T cells through arginase-1. Additionally, the proportions of granzyme BIFNγCD8 T and TNFαIFNγCD8 T cells increased after inhibition of arginase-1 signaling.
Conclusion: The impaired effector function of CD8 T cells could be restored by blocking arginase-1 signaling in patients with sepsis.
Dysregulation of neutrophil in sepsis: recent insights and advances.
Zhang J, Shao Y, Wu J, Zhang J, Xiong X, Mao J Cell Commun Signal. 2025; 23(1):87.
PMID: 39953528 PMC: 11827254. DOI: 10.1186/s12964-025-02098-y.
Huang S, Qiu X Mol Biotechnol. 2024; .
PMID: 39656406 DOI: 10.1007/s12033-024-01339-8.
Screening and identification of the hub genes in severe acute pancreatitis and sepsis.
Yang S, Luo Y, Chen B, Zhan L Front Mol Biosci. 2024; 11:1425143.
PMID: 39364223 PMC: 11446880. DOI: 10.3389/fmolb.2024.1425143.
COLEC12 Promotes Tumor Progression and Is Correlated With Poor Prognosis in Gastric Cancer.
Sun X, Zhang Q, Shu P, Lin X, Gao X, Shen K Technol Cancer Res Treat. 2023; 22:15330338231218163.
PMID: 38112409 PMC: 10734338. DOI: 10.1177/15330338231218163.
Starikova E, Rubinstein A, Mammedova J, Isakov D, Kudryavtsev I Curr Issues Mol Biol. 2023; 45(4):3525-3551.
PMID: 37185755 PMC: 10137093. DOI: 10.3390/cimb45040231.